IL1RAP and cancer: It is important to note that Il1rap, Ifi44, Timd4, Fabp3, and Eno 2 have been reported as potential therapeutic targets and potential prognostic biomarkers for several cancers [45,46,47,48,49,50,51,52,53,54,55,56,57,58,59,60].